GlassScriptPhysician profile
Katerina Gallus
NPI 1104837129
$24,232.80
in general payments reported to CMS, 2019-2025
24 companies · $1,103 in 2025
The $1,103 reported for 2025 was more than what 75% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,092 · 2020: $307 · 2021: $1,091 · 2022: $5,371 · 2023: $1,943 · 2024: $10K · 2025: $1,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,149 · Food and Beverage: $3,625 · Travel and Lodging: $387 · Long Term Medical Supply Or Device Loan: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,149.00 |
| Food and Beverage | $3,624.62 |
| Travel and Lodging | $386.94 |
| Long Term Medical Supply Or Device Loan | $211.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $10,553.20 | 2023-2025 | |
| Allergan, INC. | $4,985.05 | 2019-2022 | |
| Heron Therapeutics, INC. | $3,075.48 | 2019 | |
| Sientra, INC. | $661.14 | 2019-2022 | |
| Tepha INC | $571.69 | 2019 | |
| Mentor Worldwide LLC | $550.73 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $526.82 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Davol INC. | $496.82 | 2022-2025 | Phasix Mesh |
| Tela Bio, INC. | $441.51 | 2022-2024 | Ovitex 2s |
| Motiva USA, LLC | $310.79 | 2024 | |
| Bard Peripheral Vascular, INC. | $301.14 | 2021 | |
| Axogen | $268.02 | 2019-2025 | |
| Musculoskeletal Transplant Foundation INC. | $242.24 | 2020-2025 | |
| Rti Surgical, INC | $242.21 | 2023-2024 | |
| Becton, Dickinson and Company | $222.84 | 2025 | Phasix Mesh |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $181.83 | 2020 | |
| Kls-Martin L.P. | $158.87 | 2024 | |
| Polynovo North America LLC | $152.77 | 2023 | |
| Galderma Laboratories, L.P. | $121.73 | 2019-2023 | Dysport |
| Merz North America, INC. | $87.55 | 2019-2025 | |
| Revance Therapeutics, INC. | $30.93 | 2024 | Daxxify |
| Vertex Pharmaceuticals Incorporated | $21.22 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $14.12 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katerina Gallus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.